Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV S-ketamine crossover study of brain activation in women with varying depression vulnerability and fibromyalgia
NL-OMON49216Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in major depressive disorder (MDD) and fibromyalgia (FM) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Brain activation. Started Nov 2017; status: active, not recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)fibromyalgia (FM)
Beyond the preview
Go deeper on NL-OMON49216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49216.